One programme. The complete biological picture.
One complete programme: your genome, methylation age, medical records and wearable data brought together in a report you can understand and share.
Aevum
One evolving, understandable personal record.
Indicative pricing for 30× sequencing including the longevity signature, DNA-methylation age, a blood biomarker panel, medical-data record and wearable context, presented in one integrated report. Collection and panel details will be confirmed before purchase.
Join the waiting list- 30× whole-genome sequencing
Your whole genome sequenced once at 30× depth, with the curated 183-variant longevity signature read from the same data.
- DNA-methylation biological age
A repeatable measurement with its uncertainty stated plainly. Later measurements can show a direction of change.
- Medical data record
A comprehensive blood biomarker panel, plus results, health history and documents you share, kept together for context. Aevum does not independently interpret medical data as care. Panel details will be confirmed before purchase.
- Wearable and lifestyle data
Sleep, activity and recovery trends add day-to-day context to your evolving record.
- One integrated longitudinal report
Your genomic and methylation findings explained in plain language, with medical and wearable information alongside them and versions kept over time.
Pricing is provisional. Waiting-list registration is currently a preview and does not send your details. Nothing on this page is a purchase.
Optional additions and an existing-genome adjustment
The programme is complete on its own. These change it only where your situation calls for it.
Clinician session
A structured review of your report with a medical professional who can take it further.
Extended biomarker panel
Additional blood measurements recorded alongside your existing results, for discussion with your clinician.
Repeat measurement
An optional new methylation measurement or blood panel to add another point to your timeline.
Existing genome discount
Already hold a full, compatible whole-genome dataset? We assess it, skip the sequencing and reduce the price accordingly.
Already have your own genomic data?
Tell us what you hold. If it is complete enough to build on, we assess it and reduce the price — and we will say honestly if it is not.